(Q52174269)

English

Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia.

scientific article published in January 1999

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10501916

retrieved

26 April 2018

reference URL

http://europepmc.org/abstract/MED/10501916

title

Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10501916

retrieved

26 April 2018

reference URL

http://europepmc.org/abstract/MED/10501916

0 references

1 reference

Soignet SL

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10501916

retrieved

26 April 2018

reference URL

http://europepmc.org/abstract/MED/10501916

Tong WP

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10501916

retrieved

26 April 2018

reference URL

http://europepmc.org/abstract/MED/10501916

Hirschfeld S

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10501916

retrieved

26 April 2018

reference URL

http://europepmc.org/abstract/MED/10501916

Warrell RP Jr

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10501916

retrieved

26 April 2018

reference URL

http://europepmc.org/abstract/MED/10501916

publication date

1 January 1999

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10501916

retrieved

26 April 2018

reference URL

http://europepmc.org/abstract/MED/10501916

published in

Cancer Chemotherapy and Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10501916

retrieved

26 April 2018

reference URL

http://europepmc.org/abstract/MED/10501916

volume

44

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10501916

retrieved

26 April 2018

reference URL

http://europepmc.org/abstract/MED/10501916

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10501916

retrieved

26 April 2018

reference URL

http://europepmc.org/abstract/MED/10501916

page(s)

417-421

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10501916

retrieved

26 April 2018

reference URL

http://europepmc.org/abstract/MED/10501916

Identifiers

DOI

10.1007/S002800050998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10501916

retrieved

26 April 2018

reference URL

http://europepmc.org/abstract/MED/10501916

PubMed publication ID

10501916

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10501916

retrieved

26 April 2018

reference URL

http://europepmc.org/abstract/MED/10501916

(Q52174269)

Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)